We are a global, high-growth diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. Our proprietary T-SPOT® technology platform allows us to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body’s immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases.
This section of our website offers a significant amount of information for the investor community. If you have questions or comments after reviewing the information provided here, our Investor Relations department may be reached through the "Contact Us" tab.
Copyright Nasdaq. Minimum 15 minutes delayed.
Events & Presentations
Mar 15, 2018 10:15 AM EDT
Oxford Immunotec to Present at the Barclays Global Healthcare Conference
Mar 13, 2018 10:00 AM EDT
Oxford Immunotec to Present at the Cowen and Company 38th Annual Health Care Conference